Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Kuiper, M. Schepens, J. Thijssen, M. Asseldonk, E. Berg, J. Bridge, E. Schuuring, E. Schoenmakers, A. Kessel (2003)
Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution.Human molecular genetics, 12 14
Andrew Renshaw, S. Granter, Jonathan Fletcher, H. Kozakewich, C. Corless, Antonio Perez-Atayde (1999)
Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes.The American journal of surgical pathology, 23 7
P. Argani, M. Ladanyi (2005)
Translocation carcinomas of the kidney.Clinics in laboratory medicine, 25 2
Jeremy Clark, Yong-jie Lu, Sanjiv Sidhar, C. Parker, S. Gill, D. Smedley, R. Hamoudi, W. Linehan, J. Shipley, C. Cooper (1997)
Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinomaOncogene, 15
P. Argani, C. Antonescu, J. Couturier, J. Fournet, R. Sciot, M. Debiec-Rychter, B. Hutchinson, V. Reuter, L. Boccon-Gibod, C. Timmons, N. Hafez, M. Ladanyi (2002)
PRCC-TFE3 Renal Carcinomas: Morphologic, Immunohistochemical, Ultrastructural, and Molecular Analysis of an Entity Associated With the t(X;1)(p11.2;q21)The American Journal of Surgical Pathology, 26
J. Eble, G. Sauter, Jonathan Epstein, I. Sesterhenn, IA Sesterhehn, JN Ebele, J. Epstein (2005)
World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs
R. Ramphal, A. Pappo, M. Zielenska, R. Grant, B. Ngan (2006)
Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family.American journal of clinical pathology, 126 3
Paul Meyer, Joseph Clark, R. Flanigan, M. Picken (2007)
Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults.American journal of clinical pathology, 128 1
P. Argani, M. Laé, B. Hutchinson, V. Reuter, M. Collins, J. Perentesis, J. Tomaszewski, J. Brooks, G. Acs, J. Bridge, S. Vargas, I. Davis, D. Fisher, M. Ladanyi (2005)
Renal Carcinomas With the t(6;11)(p21;q12): Clinicopathologic Features and Demonstration of the Specific Alpha-TFEB Gene Fusion by Immunohistochemistry, RT-PCR, and DNA PCRThe American Journal of Surgical Pathology, 29
M. Ladanyi, Man Lui, C. Antonescu, A. Krause-Boehm, A. Meindl, P. Argani, J. Healey, T. Ueda, Hiroumi Yoshikawa, A. Meloni-Ehrig, P. Sorensen, F. Mertens, N. Mandahl, H. Berghe, R. Sciot, P. Cin, J. Bridge (2001)
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25Oncogene, 20
K. Chang, A. Folpe (2001)
Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors.Advances in anatomic pathology, 8 5
I. Davis, B. Hsi, Jason Arroyo, S. Vargas, Y. Yeh, Gabriela Motyckova, Patricia Valencia, A. Perez-Atayde, P. Argani, M. Ladanyi, J. Fletcher, D. Fisher (2003)
Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocationProceedings of the National Academy of Sciences of the United States of America, 100
P. Argani, A. Hawkins, C. Griffin, J. Goldstein, M. Haas, J. Beckwith, C. Mankinen, E. Perlman (2001)
A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation.The American journal of pathology, 158 6
R. Ball (2005)
Pathology and Genetics of Tumours of the Urinary System and Male Genital OrgansHistopathology, 46
P. Argani, C. Antonescu, P. Illei, Man Lui, Charles Timmons, R. Newbury, Victor Reuter, A. Garvin, A. Perez-Atayde, Jonathan Fletcher, J. Beckwith, J. Bridge, M. Ladanyi (2001)
Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.The American journal of pathology, 159 1
P. Argani, M. Laé, E. Ballard, M. Amin, C. Manivel, B. Hutchinson, V. Reuter, M. Ladanyi (2006)
Translocation carcinomas of the kidney after chemotherapy in childhood.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 10
S. Brandes (2006)
Translocation Renal Cell Carcinoma with Very Aggressive Course in Five Adult Patients
P. Argani, P. Lal, B. Hutchinson, Man Lui, V. Reuter, M. Ladanyi (2003)
Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions: A Sensitive and Specific Immunohistochemical AssayThe American Journal of Surgical Pathology, 27
Cdm Fletcher, E. Berg, Ineke Molenaar (2002)
World Health Organization Classification of Tumours
AJCP / EDITORIAL 1 2 Pedram Argani, MD, and Marc Ladanyi, MD DOI: 10.1309/EAEJTJGD5J4J3B4F The majority of renal cell carcinomas (RCCs) in adults are psammomatous calcifications. Tumors with different specific readily classified into one of several well-defined categories gene fusions may have slightly different clinical manifesta- under the 2004 World Health Organization classification, a clas- tions and morphologic features. For example, the RCCs asso- sification based on morphologic features and genetics. The types ciated with the ASPL-TFE3 gene fusion (so-called ASPL- of RCC include clear cell (conventional), papillary, chromo- TFE3 RCC) frequently present at an advanced stage and have phobe, collecting duct, and the recently described mucinous tubu- voluminous cytoplasm with extensive psammomatous calcifi- lar and spindle cell carcinoma. Many of these morphologically cations. In contrast with clear cell and papillary RCCs usual- defined entities are associated with specific genetic alterations (ie, ly seen in adults, the Xp11 translocation RCCs underexpress chromosome 3p deletion in clear cell RCC and trisomy of chro- vimentin and cytokeratins on immunohistochemical analysis, mosome 7 and 17 in papillary RCC), further validating the clas- the latter fact providing at least part of the explanation for Dr sification. Only approximately 5% of adult RCCs remain
American Journal of Clinical Pathology – Oxford University Press
Published: Sep 14, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.